Preclinical signal for a disease-modifying effect on seizure cluster severity with intermittent diazepam treatment.

Saved in:
Bibliographic Details
Title: Preclinical signal for a disease-modifying effect on seizure cluster severity with intermittent diazepam treatment.
Authors: Wu Q; Department of Pharmacy, Center for Epilepsy Drug Discovery, University of Washington, Seattle, Washington, USA., Guignet M; Department of Pharmacy, Center for Epilepsy Drug Discovery, University of Washington, Seattle, Washington, USA., Vuong J; Department of Pharmacy, Center for Epilepsy Drug Discovery, University of Washington, Seattle, Washington, USA., White HS; Department of Pharmacy, Center for Epilepsy Drug Discovery, University of Washington, Seattle, Washington, USA., Kerr WT; Departments of Neurology and Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Shih EK; Neurelis, San Diego, California, USA., Ngo LY; Neurelis, San Diego, California, USA., Carrazana E; Neurelis, San Diego, California, USA.; John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA., Rabinowicz AL; Neurelis, San Diego, California, USA.; Center for Molecular Biology and Biotechnology, Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida, USA.
Source: Epilepsia [Epilepsia] 2026 Mar; Vol. 67 (3), pp. 1497-1508. Date of Electronic Publication: 2026 Feb 02.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-1167
DOI:10.1002/epi.70051